Basel Medical Group Ltd Ordinary Shares
BMGL | NASDAQ
$5.04
+$0.29 (+6.11%)
At close: Oct 30, 2026, 4:00 PM ET
$4.97
-$0.07 (-1.39%)
Pre-market:
Nov 2, 2026, 7:35 AM ET
+6.11%
(1D)No price chart data available for 1D timeframe.
Rating
16
+3.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1013/1028 (Top 99%)
Key Statistics
Market Data
Market Cap $7.97M
1D Range
4.75 5.07
52W Range
3.02 18.60
Valuation (TTM)
PE -18.79
PB 1.63
EV/EBITDA -11.20
Valuation (NTM)
Forward PE N/A
Forward PEG -0.24
Price Target $0.00
Cash Flow
FCF Yield -25.3%
SBC Adj. FCF Yield -25.3%
SBC Impact N/A
Margins
Gross Margin 0.3%
Operating Margin -31.7%
FCF Margin -18.0%
Growth (CAGR)
Revenue 3Y | 5Y 2.0% |
N/A
Dil EPS 3Y | 5Y -300.2% |
N/A
FCF 3Y | 5Y -1506.4% |
N/A
Returns
ROA -47.4%
ROE -164.2%
ROIC -24.8%
Financial Health
Net Debt
S$4.5M ($3.5M)
Current Ratio 1.88
Interest Coverage -13.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including speciali...
Sector Healthcare
Industry Medical - Care Facilities
Employees 82
IPO Date Feb 25, 2025
Website baselmedical.com
Fiscal Year July - June
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove BMGL